P539: PROGNOSTIC RELEVANCE OF MINIMAL RESIDUAL DISEASE IN THERAPY RELATED AND SECONDARY ACUTE MYELOID LEUKEMIA RECEIVING CPX-351 OR FLUDARABINE-BASED INDUCTION. (23rd June 2022) - Guolo, F.; Minetto, P.; Riva, C.; Parodi, F.; Miglino, M.; Tedone, E.; Colombo, N.; Carminati, E.; Nurra, C.; Cagnetta, A.; Cea, M.; Lemoli, R. M.